For: | Worland T, Hey P, Wong D, Apostolov R, Chan RK, Sinclair M, Gow P. Rifaximin-α use is associated with improved muscle mass in patients with cirrhosis. World J Hepatol 2025; 17(4): 104056 [PMID: 40308826 DOI: 10.4254/wjh.v17.i4.104056] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v17/i4/104056.htm |
Number | Citing Articles |
1 |
Mohamed El-Kassas, Khalid AlNaamani. Rifaximin and sarcopenia in cirrhosis: Commentary on a promising but complex relationship. World Journal of Hepatology 2025; 17(9): 108951 doi: 10.4254/wjh.v17.i9.108951
|